Health economic evaluation of a serum-based blood test for brain tumour diagnosis: exploration of two clinical scenarios

Abstract

Use of this test as triage tool in primary care has the potential to be both more effective and cost saving for the health service. In secondary care, this test would also be deemed more effective than the current diagnostic pathway.